Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal] (2017)
- Authors:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1111/nmo.12988
- Subjects: DOENÇAS VASCULARES; FARMACOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Neurogastroenterology & Motility
- ISSN: 1350-1925
- Volume/Número/Paginação/Ano: v. 29, n. 2, art. e12988, 2017
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
AMARAL, Jefferson Henrich e TANUS-SANTOS, José Eduardo. Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal]. Neurogastroenterology & Motility. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1111/nmo.12988. Acesso em: 14 out. 2024. , 2017 -
APA
Amaral, J. H., & Tanus-Santos, J. E. (2017). Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal]. Neurogastroenterology & Motility. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1111/nmo.12988 -
NLM
Amaral JH, Tanus-Santos JE. Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal] [Internet]. Neurogastroenterology & Motility. 2017 ; 29( 2):[citado 2024 out. 14 ] Available from: https://doi.org/10.1111/nmo.12988 -
Vancouver
Amaral JH, Tanus-Santos JE. Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal] [Internet]. Neurogastroenterology & Motility. 2017 ; 29( 2):[citado 2024 out. 14 ] Available from: https://doi.org/10.1111/nmo.12988 - Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6
- Sequence diversity and functional charactterization of the 5´-regulatory region of human cyp2c19
- Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction
- Nitrate decreases xanthine oxidoreductase-mediated nitrite reductase activity and attenuates vascular and blood pressure responses to nitrite
- eNOS gene polymorphirms may modify the effects produced by cardiovascular drugs on myocardial eNOS expression and activity [Carta]
- Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes
- Hemodynamic effects of bupropion in anesthetized dogs
- Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism
- Severity dependent increases in circulating cardiac troponin I and MMP-9 concentrations after experimental acute pulmonary thromboembolism
- Functional polymorphism located in MMP-9 gene promoter is strongly associated with obesity
Informações sobre o DOI: 10.1111/nmo.12988 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas